Fidanacogene elaparvovec, sold under the brand name Beqvez among others, is a gene therapy delivered via adeno-associated virus used for the treatment...
16 KB (1,087 words) - 10:40, 29 September 2024
Spark Therapeutics (section Fidanacogene elaparvovec)
treatment of Leber's congenital amaurosis, a rare genetic eye disease. Fidanacogene elaparvovec, previously known by its study ID number SPK-9001, is a gene therapy...
10 KB (869 words) - 10:18, 29 September 2024
fibrinogen (125 I) (INN) FibriScint fibrinolysin (human) (INN) fidanacogene elaparvovec (INN) fidarestat (INN) fidaxomicin (USAN, INN) fidexaban (USAN)...
2 KB (191 words) - 04:22, 2 July 2024
obtained Breakthrough Therapy designation and FDA approval for Fidanacogene elaparvovec to treat Hemophilia B and Breakthrough Therapy designation for...
15 KB (1,438 words) - 10:00, 29 September 2024
Susoctocog alfa, Turoctocog alfa, Valoctocogene roxaparvovec) IX/(Fidanacogene elaparvovec, Nonacog alfa) extrinsic: VII/Eptacog alfa common: X II/Thrombin...
9 KB (964 words) - 13:43, 15 November 2022